PMID: 8938274Dec 1, 1995Paper

Augmenting the immunogenicity of carbohydrate tumor antigens

Seminars in Cancer Biology
P O Livingston

Abstract

Antibody responses have identified cell surface carbohydrate antigens as potentially immunogenic cancer antigens in a variety of different tumors, but immunization with whole tumor cells or cell lysates has only occasionally induced immune responses against these antigens. Three approaches to further augmenting their immunogenicity have been explored, mixture with immunological adjuvants, synthesis of more immunogenic derivatives and conjugation to immunogenic proteins. Conjugation to proteins such as KLH plus the use of potent adjuvants such as QS-21 proved most immunogenic. Carbohydrate epitopes on gangliosides (GM2 and GD2), neutral glycolipids (Ley and Globo H) and glycoproteins (Ley, Globo H, TF, sTn and Tn) are of special interest. Each of these antigens has been synthesized and conjugated to KLH. Their use in preclinical or clinical vaccination studies has resulted in increased IgM and IgG antibody responses against tumors expressing these antigens. Phase I-II clinical trials in patients with cancer have been initiated with each to optimize immunogenicity. The GM2 vaccine has progressed to Phase III trials and the sTn vaccine to Phase II trials aimed at determining the impact of vaccination on survival.

References

May 30, 1991·International Journal of Cancer. Journal International Du Cancer·G RitterP Livingston
Jan 1, 1989·Cancer Immunology, Immunotherapy : CII·P O LivingstonM J Calves
May 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·P O LivingstonL J Old
Sep 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N K CheungN A Berger
Feb 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·A N HoughtonL J Old
May 15, 1985·International Journal of Cancer. Journal International Du Cancer·T TaiD L Morton
Jun 1, 1983·The Journal of Infectious Diseases·H KäyhtyP H Mäkelä
Jun 15, 1984·Science·G F Springer
May 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R A GhosseinJ Rosai
Sep 15, 1995·International Journal of Cancer. Journal International Du Cancer·G RitterP O Livingston
Mar 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·H NakadaI Yamashina
Mar 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·K KitamuraL J Old
Feb 1, 1994·Molecular and Chemical Neuropathology·F Helling, P O Livingston
May 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P O LivingstonG Ritter
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F PerroneM I Colnaghi
Feb 20, 1993·International Journal of Cancer. Journal International Du Cancer·W B HamiltonP O Livingston
Jan 1, 1993·Cancer Immunology, Immunotherapy : CII·G D MacLeanB M Longenecker
May 1, 1913·The Journal of Experimental Medicine·S Flexner
Jun 30, 1923·The Journal of Experimental Medicine·M Heidelberger, O T Avery

❮ Previous
Next ❯

Citations

Jun 6, 2003·Cancer Treatment Reviews·Joseph M KaminskiBoris Minev
Jun 15, 2000·Bioorganic & Medicinal Chemistry Letters·Q WangR J Linhardt
Nov 2, 1999·Micron : the International Research and Review Journal for Microscopy·J R Harris, J Markl
Apr 27, 2000·Critical Reviews in Oncology/hematology·A J Bremers, G Parmiani
Oct 31, 2009·The Journal of Organic Chemistry·Insik JeonSamuel J Danishefsky
Sep 3, 2005·Nature Reviews. Drug Discovery·Peter H Seeberger, Daniel B Werz
Aug 12, 2008·Proceedings of the National Academy of Sciences of the United States of America·Cheng-Chi WangChi-Huey Wong
May 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Cory L BrooksStephen V Evans
May 13, 1999·Proceedings of the National Academy of Sciences of the United States of America·S F SlovinH I Scher
Dec 18, 2003·Hybridoma and Hybridomics·Mabel RodríguezAna María Vázquez
Sep 1, 2009·Journal of Experimental & Clinical Cancer Research : CR·Marina Isla LarrainMaría Virginia Croce
Oct 3, 2002·Proceedings of the National Academy of Sciences of the United States of America·Govindaswami RagupathiSamuel J Danishefsky
Nov 26, 2014·Expert Review of Vaccines·Ana María Hernández, Ana María Vázquez
Jun 29, 2004·International Journal of Cancer. Journal International Du Cancer·John SotiriadisYoon Berm Kim
Oct 7, 2009·Expert Review of Vaccines·Jianglong ZhuSamuel J Danishefsky
Oct 31, 2006·The Journal of Investigative Dermatology. Symposium Proceedings·Ulrich auf dem KellerSabine Werner
Jan 22, 2010·Expert Opinion on Biological Therapy·Mayrel LabradaLuis E Fernández
Aug 11, 2015·RSC Advances·Satadru S MandalZhongwu Guo
Dec 3, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Susan F SlovinHoward I Scher
Jan 1, 2011·Cancers·Klervi Even-DesrumeauxPatrick Chames
Mar 16, 2012·Future Medicinal Chemistry·Rachel Hevey, Chang-Chun Ling
Nov 7, 2015·Biochemistry. Biokhimii︠a︡·N R Khasbiullina, N V Bovin
Oct 23, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ana María HernándezRolando Pérez
Jun 12, 1998·Journal of Surgical Oncology·M L Salgaller, P A Lodge
May 3, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sailyn AlfonsoAmparo E Macías
Jul 17, 2018·Chemical Reviews·Liuqing WenPeng George Wang
Aug 8, 2008·Seminars in Immunology·Andrea SchietingerHans Schreiber
Nov 10, 2005·The Journal of Organic Chemistry·Dino K RessRobert J Linhardt
Oct 14, 2006·Science·Andrea SchietingerHans Schreiber

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.